Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Complete panel of pulmonology. NGS panel of 66 genes. Genologica Medica Spain | 115 | 66 |
|
Bronchiectasis panel. NGS panel of 15 genes. Genologica Medica Spain | 19 | 15 |
|
Plugin system clutter panel. NGS panel of 75 genes. Genologica Medica Spain | 76 | 75 |
|
Ciliary dyskinesia and heterotaxia. NGS panel of 40 genes. Genologica Medica Spain | 49 | 40 |
|
Primary ciliary dyskinesia panel. 36-gene NGS panel. Genologica Medica Spain | 46 | 35 |
|
Heterotaxy and situs inversus panel. 32-gene NGS panel. Genologica Medica Spain | 34 | 31 |
|
CCDC39 Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 1 | 1 |
|
Asper Biogene Asper Biogene LLC Estonia | 166 | 120 |
|
Primary Ciliary Dyskinesia Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 30 | 20 |
|
Al Jalila Children’s Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 64 | 66 |
|
Primary Ciliary Dyskinesia panel Al Jalila Children’s Genomics Center Al Jalila Childrens Speciality Hospital United Arab Emirates | 36 | 38 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
Primary Ciliary Dyskinesia NGS Panel Fulgent Genetics United States | 55 | 38 |
|
Congenital Heart Defect NGS Panel Fulgent Genetics United States | 377 | 114 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
Beacon Expanded Male Carrier Screening Panel Fulgent Genetics United States | 636 | 298 |
|
Beacon Expanded Male Carrier Screening Plus Panel Fulgent Genetics United States | 661 | 306 |
|
Beacon Expanded Female Carrier Screening Panel Fulgent Genetics United States | 690 | 326 |
|
Asper Biogene Asper Biogene LLC Estonia | 33 | 35 |
|
Ambry Genetics United States | 30 | 21 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.